1994
DOI: 10.1016/s0264-410x(94)80054-4
|View full text |Cite
|
Sign up to set email alerts
|

Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
43
0

Year Published

2000
2000
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(43 citation statements)
references
References 20 publications
0
43
0
Order By: Relevance
“…[7][8][9][10] Among the different cell constituents, two surface components are mainly being discussed as candidates for an anti-Klebsiella vaccine: LPS and CPS. 11,12 While the utilization of LPS antigens in Klebsiella vaccines is favored by the existence of only 9 different O-types, the adverse toxic reactions present a great drawback of active immunization with LPS-containing vaccines, although they can be reduced by detoxification.…”
Section: Identification and Characterization Of Antigens As Vaccine Cmentioning
confidence: 99%
“…[7][8][9][10] Among the different cell constituents, two surface components are mainly being discussed as candidates for an anti-Klebsiella vaccine: LPS and CPS. 11,12 While the utilization of LPS antigens in Klebsiella vaccines is favored by the existence of only 9 different O-types, the adverse toxic reactions present a great drawback of active immunization with LPS-containing vaccines, although they can be reduced by detoxification.…”
Section: Identification and Characterization Of Antigens As Vaccine Cmentioning
confidence: 99%
“…Early studies suggest that LPS-deficient strains failed to show significantly different pathogenesis from the wild-type (WT) strain (5). By contrast, CPS demonstrates the most distinguished characteristic of virulence factors for K. pneumoniae, and is implicated in the internalization of pathogens into epithelial cells (6). The capsule may protect the bacterium from phagocytosis by macrophages, through an escape from bactericidal serum factors (6).…”
mentioning
confidence: 99%
“…By contrast, CPS demonstrates the most distinguished characteristic of virulence factors for K. pneumoniae, and is implicated in the internalization of pathogens into epithelial cells (6). The capsule may protect the bacterium from phagocytosis by macrophages, through an escape from bactericidal serum factors (6). Other studies also demonstrated that isogenic CPS mutant strains of K. pneumoniae exhibited higher levels of adherence and internalization to lung cells and were more invasive, compared with WT counterparts (4).…”
mentioning
confidence: 99%
“…pneumoniae is considered an extracellular pathogen whose virulence is linked with the production of a polysaccharide capsule that provides protection against host defense mechanisms, particularly phagocytosis (8). Immunity against the encapsulated bacterium is largely mediated by antibodies specific for the capsular polysaccharide, an observation that has been exploited to develop prototypic vaccines against the bacterium (13). As with other capsule-based vaccines, e.g., 23-valent pneumococcus vaccine, the efficacy of similar K. pneumoniae vaccines will depend on the distribution of capsule or "K" serotypes (5,6).…”
mentioning
confidence: 99%